Is Haleon plc (HLN) a Buy, Sell, or Hold?
Haleon plc
NYSE:HLN
$9.7 USD
-$0.16 (-1.62%)
- Volume
- 4.29M
- Average Volume
- 9.06M
- Market Capitalization
- $42.72B
- P/E Ratio
- 19.21
- Dividend Yield
- 1.99%
- Price Target
- $10.20
- Year High
- $11.28
- Year Low
- $8.65
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.37
- Current Ratio
- $0.92
Industry, Sector & symbol
| Stock Exchange | NYSE |
| CEO | Brian James McNamara |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Current Symbol | HLN |
| CUSIP | 405552100 |
| CIK | 0001900304 |
| Web | https://www.haleon.com |
| Phone | 44 1932 822000 |
| Currency | USD |
| Employees | 24535 |
| Country | GB |
Liquidity
| Debt-to-Equity Ratio | 0.52 |
| Payout Ratio | 0.37 |
| Current Ratio | 0.92 |
| Quick Ratio | 0.71 |
| Cash Ratio | 0.27 |
Sales & Book Value
| Annual Sales | $11.03B |
| Price / Sales | 2.85 |
| Cash Flow | 0.13 |
| Price / Cash Flow | 26.52 |
| Price / Book | 1.95 |
Price Target and Rating
| Average Stock Price Forecast | $10.20 |
| High Stock Price Forecast | $10.20 |
| Low Stock Price Forecast | $10.20 |
| Forecast Upside/Downside | -4.90% |
| Consensus Rating | Buy |
| Rating Score(0-5) | 4 |
| Research Coverage | 4 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $0.36 |
| Trailing P/E Ratio | 19.21 |
| PEG Ratio | 1.02 |
| P/E Growth | 1.02 |
| Net Income | $1.63B |
| Net Margin | 15.11% |
| Pretax Margin | 19.51% |
| Return on Equity | 10.30% |
| Return on Assets | 5.11% |
Financials Score
| AltmanZ Score | 2.89 |
| Piotroski Score | 8.00 |
| Working Capital | -382.33M |
| Total Assets | 32.57B |
| Ebit | 4.24B |
| Market Cap | 32.05B |
| Total Liabilities | 16.12B |
Poll Results
About Haleon plc (NYSE:HLN) Stock
Haleon plc is a significant global entity in the consumer healthcare sector, engaging in the entire process from scientific research and development to the production and worldwide distribution of various wellness goods. The company's reach extends across North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific region. Its diverse product portfolio encompasses therapeutic solutions for oral care, pain management, respiratory well-being, and digestive health, alongside a comprehensive range of vitamins, minerals, and other dietary supplements. Noteworthy brands within its collection include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. Established in 2021, the company was initially known as DRVW 2022 plc before official ... ly changing its name to Haleon plc in February 2022. It is headquartered in Brentford, United Kingdom.
LCUT vs. HLN: Which Stock Is the Better Value Option?
2026-07-01 12:40:36
Investors interested in stocks from the Consumer Products - Discretionary sector have probably already heard of Lifetime Brands (LCUT) and Haleon PLC Sponsored ADR (HLN). But which of these two stocks offers value investors a better bang for their buck right now?
Haleon Bets on Microsoft AI To Support Growth and Reach One Billion More Consumers by 2030
2026-07-01 11:54:05
Haleon plc (NYSE:HLN) has entered into a new five-year collaboration with Microsoft Corp. (NASDAQ:MSFT) to expand its digital, data, and artificial intelligence capabilities as the consumer health company looks to accelerate its global “Win as One” strategy.
Haleon to Accelerate AI-powered Transformation With New Five-year Microsoft Collaboration
2026-07-01 05:00:00
LONDON--(BUSINESS WIRE)-- #AI--Haleon, a consumer health company solely focused on better everyday health, today announces a new five-year collaboration with Microsoft to scale digital, data and AI capabilities across the business and accelerate delivery of its global Win as One strategy. The new agreement builds on Haleon's existing use of Microsoft 365 Copilot and further supports the wider adoption of AI-powered tools across the business, helping teams automate routine tasks, collaborate more effe.
Nasdaq leads Wall Street higher at the open as uneasy Iran truce holds
2026-06-29 08:30:00
12:30pm: Tech strength The Nasdaq continued to lead stocks higher in the early afternoon on Monday, up 1.4% while the S&P 500 was up 0.8% and the Dow Jones...
Futura swaps Haleon for Market Performance Group to drive US Eroxon sales - UPDATE
2026-06-29 05:51:00
Share in Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX) rose 19% to 0.6p after it ended its US partnership with consumer health giant Haleon PLC (LSE:HLN,...
LCUT or HLN: Which Is the Better Value Stock Right Now?
2026-06-15 12:41:09
Investors looking for stocks in the Consumer Products - Discretionary sector might want to consider either Lifetime Brands (LCUT) or Haleon PLC Sponsored ADR (HLN). But which of these two stocks presents investors with the better value opportunity right now?
Haleon Invests in India to Deliver Better Everyday Health to Rural Communities
2026-06-08 05:11:00
LONDON--(BUSINESS WIRE)-- #AI--Haleon, a consumer company that is solely focused on better everyday health, today announces plans to expand its business in India, one of its fastest-growing markets and key to Haleon delivering its strategy and ambitions to reach one billion more consumers by 2030. Haleon will invest approximately £175 million2 in building a new oral health manufacturing site in Madhya Pradesh, central India and accelerate distribution efforts in rural India to meet rising demand. The.
Haleon Issues Voluntary Nationwide Recall of Gas-X Extra Strength Softgels 125mg, 120 ct. and 72 ct.
2026-06-04 14:32:00
WARREN, N.J.--(BUSINESS WIRE)--Haleon (NYSE: HLN) is voluntarily recalling four lots of Gas-X Extra Strength Softgels 125mg, 120 ct. and 72 ct. distributed on or about April 13, 2026 to the consumer level. The lots are being recalled due to potential contamination with a diluted propylene glycol-based coolant from a machine leakage during the packaging process. There is a potential that ingestion of the Softgels contaminated with the diluted propylene glycol-based coolant may result in adverse.
Frequently Asked Questions
-
What is the current Haleon plc (HLN) stock price?
-
Haleon plc(NYSE:HLN) stock price is $9.7 in the last trading session. During the trading session, HLN stock reached the peak price of $11.28 while $8.65 was the lowest point it dropped to. The percentage change in HLN stock occurred in the recent session was --1.62% while the dollar amount for the price change in HLN stock was -$-0.16.
-
HLN's industry and sector of operation?
-
The NYSE listed HLN is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.
-
Who are the executives of HLN?
-
Adrian Charles Morris | General Counsel
Bjorn Timelin | Head of Strategy
Brian James McNamara | Chief Executive Officer & Executive Director
Filippo Lanzi | President of EMEA & LatAm
Keith Choy | President of Asia Pacific -
How many employees does HLN have?
-
Number of HLN employees currently stands at 24535. HLN operates from Building 5, Weybridge, None KT13 0NY, GB.
-
Link for HLN official website?
-
Official Website of HLN is: https://www.haleon.com
-
How do I contact HLN?
-
HLN could be contacted at phone #44 1932 822000 and can also be accessed through its website. HLN operates from Building 5, Weybridge, None KT13 0NY, GB.
-
How many shares of HLN are traded daily?
-
The average number of HLN shares traded daily for last 3 months was 9.06M.
-
What is the market cap of HLN currently?
-
The market value of HLN currently stands at $42.72B with its latest stock price at $9.7